7 completed, 6 unknown, 1 not yet recruiting, 1 terminated. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 7, Unknown 6, Not yet recruiting 1, Terminated 1 |
Follow Fluvoxamine: new trials by email Literature Review of Fluvoxamine trials Research Report on Fluvoxamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Hydroxyzine for Patients With Panic Disorder Hydroxyzine, Escitalopram Oxalate - Panic Disorder | Phase 4 | Not yet recruiting | Sultan Qaboos University | 80 | 2023-12-30 | 2023-02-21 |
| Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community FluvoxaMINE Maleate 50 MG, Fluvoxamine, Bromhexine, Fluvoxamine, Cyproheptadine - Treatment Efficacy | Phase 4 | Completed | Chulalongkorn University | 1200 | 2021-10-01 | 2022-11-04 |
| Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder sertraline fluvoxamine, sertraline - OCD | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 400 | 2020-01-01 | 2021-07-15 |
| Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment Vortioxetine, Sertraline, citalopram - Major Depressive Disorder | Phase 4 | Completed | Azienda Ospedaliera Universitaria Integrata Verona | 362 | 2019-02-01 | 2023-05-19 |
| Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics Fluoxetine, fluoxetine + cognitive-behavioral treatment（CBT）, fluoxetine + Amfebutamone - Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 800 | 2017-08-01 | 2017-10-10 |
| Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients Fluoxetine, Sertraline, Paroxetine - Obsessive-Compulsive Disorder, Anxiety Disorders | Phase 4 | Completed | Shanghai Mental Health Center | 78 | 2014-01-01 | 2022-09-09 |
| Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine Fluvoxamine - Recurrent Depressive Disorder | Phase 4 | Completed | Moscow Research Institute of Psychiatry | 50 | 2013-12-01 | 2015-07-21 |
| Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications SSRI/SNRI - Depressive Disorder, Lactation | Phase 4 | Unknown | Centre Hospitalier Universitaire Vaudois | 500 | 2012-08-01 | 2015-07-28 |
| Algorithm Guided Treatment Strategies for Major Depressive Disorder Escitalopram, Mirtazapine, modified electroconvulsive therapy - Major Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 1080 | 2012-06-01 | 2013-01-10 |
| Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder SSRI antidepressants, Cognitive-Behavior Therapy - Major Depressive Disorder | Phase 4 | Unknown | Nanjing Medical University | 80 | 2011-12-01 | 2014-09-25 |
| Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD) Luvox CR, Behavioral Therapy - Obsessive Compulsive Disorder | Phase 4 | Unknown | Rogers Center for Research & Training, Inc. | 50 | 2008-09-01 | 2008-09-04 |
| Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine clozapine plus fluvoxamine, clozapine plus placebo - Schizophrenia | Phase 4 | Completed | Taipei Medical University Hospital | 80 | 2008-01-01 | 2011-07-25 |
| Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents Fluvoxamine maleate, Placebo - Major Depressive Disorder | Phase 4 | Completed | Solvay Pharmaceuticals | 90 | 2006-10-01 | 2010-03-04 |
| Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents Fluvoxamine maleate, Placebo - Obsessive Compulsive Disorder | Phase 4 | Terminated | Solvay Pharmaceuticals | 20 | 2006-08-01 | 2010-03-04 |
| Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression Selective serotonin reuptake inhibitors (SSRI) - Major Depressive Disorder | Phase 4 | Completed | Massachusetts General Hospital | 95 | 2003-04-01 | 2008-05-28 |
Depressive Disorder, Major (5) · Depression (4) · Depressive Disorder (3) · Obsessive-Compulsive Disorder (3) · Anxiety Disorders (1) · Breast Feeding (1) · COVID-19 (1) · Coronavirus Infections (1) · Mental Disorders (1) · Metabolic Syndrome (1) · Panic Disorder (1) · Pneumonia, Viral (1) · Recurrence (1) · Respiratory Tract Infections (1) · Schizophrenia (1)
Shanghai Mental Health Center (3) · Solvay Pharmaceuticals (2) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Centre Hospitalier Universitaire Vaudois (1) · Chulalongkorn University (1) · Massachusetts General Hospital (1) · Moscow Research Institute of Psychiatry (1) · Nanjing Medical University (1) · Rogers Center for Research & Training, Inc. (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Sultan Qaboos University (1) · Taipei Medical University Hospital (1)
China (5) · Japan (2) · France (1) · Italy (1) · Russia (1) · Switzerland (1) · Taiwan (1) · Thailand (1) · United States (1)
Toshiaki Yamaguchi (2) · Alexey E. Bobrov, Professor (1) · Cameron Hurst, PhD (1) · Chantal Csajka, Prof PhD (1) · Chun Wang, doctor (1) · Dan Iosifescu, MD (1) · Dhammika Leshan Wannigama, MD PhD (1) · John H Greist, MD (1) · Kanokpoj Chanpiwat, MD (1) · Katika Akksilp, MD (1) · Mong-Liang Lu (1) · Shuichi Abe, MD (1) · Yiru Fang, Ph.D., M.D. (1) · Zhen Wang, Ph.D, M.D (1)
PMID 19574030, PMID 28688742, PMID 32162723, PMID 32746941, PMID 33116533, PMID 35018097, PMID 36189181, PMID 37920522, PMID 38384338, PMID 38516100, PMID 40679716
2016 (1), 2018 (1)